An expanding toolbox is driving unprecedented acceleration in life science innovation. Many new and emerging advanced therapies are entering the clinic driven by academia and a vibrant start-up community. A significant challenge in this space is access to drug development expertise to help in the translational journey from the lab bench to the clinic. Landmark Bio was created to bring together the best of academia, industry and research hospitals to accelerate breakthrough innovations in advanced therapies. This talk will explore how Landmark is bringing drug development expertise and flexible biomanufacturing capacity to enable therapeutic translation of advanced therapies.